Transitional cell carcinoma of the prostate: response to treatment with cisplatinum and cyclophosphamide.
We observed a remarkable clinical response to cisplatinum and cyclophosphamide in a patient with widespread metastatic transitional cell cancer of the prostate after hormonal therapy proved ineffective. Combination chemotherapy has the potential for an impressive response in these patients.